Osteo Arthritis Knee Clinical Trial
Official title:
A Prospective Randomized Trial on the Use of Tourniquet in Primary Total Knee Arthroplasty
NCT number | NCT04502459 |
Other study ID # | UW 15-129 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 5, 2015 |
Est. completion date | December 15, 2017 |
Verified date | August 2020 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A tourniquet is often used in total knee arthroplasty (TKA) to achieve better visualization, reduce intra-operative bleeding and facilitate cement interdigitation. On the other hand, the associated risks include skin burns, soft tissue and muscle damage, injury of calcified vessels, increased swelling and stiffness of the joints, nerve injury, paralysis, and thromboembolic events. The automatic lower limb pneumatic tourniquet system (Zimmer) was applied to reduce blood loss during surgery. A prospective randomized controlled trial (RCT) was performed to investigate the best tourniquet strategy in TKA. The participants were randomly allocated to groups with different tourniquet strategies: Group 1) tourniquet inflation from skin to cement hardening (skin to cement); Group 2) tourniquet inflation only from cementation (cement only) and Group 3) tourniquet inflation from skin incision to skin closure (skin to skin). In addition to the blood loss and early postoperative outcomes, pain, soft tissue injury, and rehabilitation were also strictly monitored with a longer follow-up duration up to 6 months.
Status | Completed |
Enrollment | 90 |
Est. completion date | December 15, 2017 |
Est. primary completion date | December 15, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patients suffer from primary osteoarthritis indicated for total knee arthroplasty 2. Subject is physically and mentally willing and able to comply with the postoperative scheduled clinical and radiographic evaluations 3. Subject must have signed an informed consent document specific to the study, and approved by the Ethics Committee, indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study Exclusion Criteria: 1. Subject requires a revision knee arthroplasty surgery 2. Subject is currently on anti-coagulant therapy or has coagulopathy 3. Subject has peripheral vascular disease of the lower limb evidenced by the presence of blood vessel calcification on the radiographs or the absence of dorsalis pedis/popliteal pulses 4. Subject suffers from conditions other than primary knee osteoarthritis, e.g. inflammatory arthritis 5. Subject having associated medical diseases affecting rehabilitation 6. Subject has active systemic infection or infection near the knee joint 7. Subject having current medical condition that render them unfit for surgery 8. Any criterion which in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong |
Tai TW, Chang CW, Lai KA, Lin CJ, Yang CY. Effects of tourniquet use on blood loss and soft-tissue damage in total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2012 Dec 19;94(24):2209-15. doi: 10.2106/JBJS.K.00813. — View Citation
Tarwala R, Dorr LD, Gilbert PK, Wan Z, Long WT. Tourniquet use during cementation only during total knee arthroplasty: a randomized trial. Clin Orthop Relat Res. 2014 Jan;472(1):169-74. doi: 10.1007/s11999-013-3124-2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Loss | We calculated the intraoperative blood loss by measuring the suction volume and weighing the sponges. Hemoglobin (Hb) and hematocrit (Hct) levels were examined preoperatively, and on Day 1 to Day 4 after surgery. Change of Hb and Hct was calculated as the value of postoperative D1 to D4 minus preoperative value. The number of patients undergoing blood transfusion were recorded. The criterion for a blood transfusion was set as a Hb level of <8 g/dL with symptomatic anemia. The calculated blood loss, which re?ects actual blood loss, was determined with use of a previously described method. Briefly, the patients blood volume (PBV) is calculated using a formula, and multiplying the PBV by the change of haematocrit (preoperative value minus value on postoperative Day 2) will give the estimated total blood loss (ETBL). | 4 days after surgery | |
Secondary | Soft-tissue damage | We assessed soft-tissue damage by examining serum C-reactive protein (CRP), creatine kinase (CK), lactate dehydrogenase (LDH), and interleukin-6 (IL-6) levels preoperatively and on postoperative days 1, 2, 3 and 4 | 4 days after surgery | |
Secondary | Thigh circumference | Thigh circumference was measured 10 cm proximal to the patella and leg circumference was measured 15 cm distal to the patella, to determine the degree of swelling, and was measured on postoperative days 1, 2, 3 and 4. X-rays were taken after surgery to measure the lower limb alignment, and tibial and femoral components position. | 4 days after surgery | |
Secondary | Postoperative Visual Analog Scale | Postoperative visual analog scale (VAS) scores were obtained for both knee and thigh pain preoperatively and on postoperative. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | Peak Quadriceps Strength | The strength of each leg was evaluated by using an isokinetic dynamometer. Peak torque measured in both the concentric and eccentric modes. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | Time-up-and-go (TUG) Test | he TUG test was used to evaluate the preoperative degree of mobility. This test involves measuring the time a patient needs to get up from a chair, walk three meters, turn, walk back to the chair and then sit down again. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | 6-minute Walking Test | A test that evaluates the functional capacity of the patient while walking on a flat, hard surface in the 6-minute window. It assess all the systems that are involved in the 6-minute window. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | Berg Balance Scale | The BBS test is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | Knee Society Knee Score | A knee score that rates only the knee joint itself, there are three main parameters which are pain, stability and the range of motion. Whereas flexion contracture, extension lag and misalignment would be different ways for point deductions. 100 points would refer to a patient with no knee pain, 125 degree range of motion and negligible anteroposterior and mediolateral instability. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 | |
Secondary | Knee Society Function Score | A functional score that rates the patient's ability to walk and climb stairs, points would be deducted if the patient uses any walking aids for the two. 100 points would refer to a patient that can walk for an unlimited distance and go up and down the stairs without any trouble. | Day 1, Day 2, Day 3, Day 4, Day 7, Week 6, Month 3, and Month 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04040985 -
Legion Primary Safety and Efficacy
|
N/A | |
Active, not recruiting |
NCT04525950 -
Robotized Navigation Compared to Conventional Technique in Total Knee Replacement
|
N/A | |
Recruiting |
NCT04320914 -
High Intensity Laser Therapy (Classes IV) and Ibuprofen Gel Phonophoresis for Treating Knee Osteoarthritis
|
N/A | |
Completed |
NCT03886142 -
Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis
|
N/A | |
Terminated |
NCT04072055 -
MOTO Post-marketing Surveillance Study
|
||
Not yet recruiting |
NCT06385275 -
The Role of Vitamin K on Knee Osteoarthritis Outcomes
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05290818 -
Total Versus Robotic Assisted Unicompartmental Knee Replacement
|
N/A | |
Withdrawn |
NCT03271229 -
Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee
|
Phase 2 | |
Recruiting |
NCT05505552 -
Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:
|
N/A | |
Recruiting |
NCT05992038 -
Use of a Putty as Gap Filler in Open-wedge Osteotomy
|
N/A | |
Recruiting |
NCT06066684 -
Pain Phenotyping in Knee OA: a Pilot Trial
|
||
Completed |
NCT03847324 -
Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05126485 -
Biofeedback Retention in Individuals With AKA
|
Early Phase 1 | |
Completed |
NCT04956393 -
The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study
|
N/A | |
Recruiting |
NCT04541342 -
Arthroscopic Evaluation of Cartilage Regeneration After Opening-wedge High Tibial Osteotomy
|
N/A | |
Completed |
NCT04391842 -
Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis
|
Phase 1 | |
Completed |
NCT03680807 -
Power Production in Older Adults With Knee Osteoarthritis
|
||
Completed |
NCT03783455 -
Effectiveness of Five Intraarticular Strategies on Knee Osteoarthritis
|
N/A | |
Not yet recruiting |
NCT06264362 -
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
|
N/A | |
Completed |
NCT05089253 -
Effect of Physical Therapy Modalities in Osteoarthritis
|
N/A |